CD82 and sarcoma: As gp78 contributes to tumor progression as reported in sarcoma metastasis by targeting KAI1 for degradation [32] and mammary gland hyperplasia by MMTV-driven 78 transgenic overexpression [33], gp78 is likely to play an opposing roles of tumor suppression or promotion according to tissue context and tumor stages.